Primary progressive aphasia: from syndrome to disease
- PMID: 22703637
- DOI: 10.1016/j.nrl.2012.04.003
Primary progressive aphasia: from syndrome to disease
Abstract
Introduction: Primary progressive aphasia (PPA) is a clinical syndrome characterised by a progressive decline in language and speech of neurodegenerative origin. Major breakthroughs made in recent years have lent us a better understanding of this syndrome, which may be the first manifestation of any of a number of neurodegenerative diseases.
Development: We reviewed the main aspects of PPA epidemiology, clinical manifestations, diagnosis, aetiology and treatment. Most cases manifest sporadically and the typical age of onset is between 50 and 70 years. Three clinically distinct variants have been described: nonfluent or agrammatic PPA, semantic PPA and logopenic PPA. Each of these variants tends to be associated with specific histopathological findings, but clinical diagnostic methods are imperfect predictors of underlying pathology. Anatomical and functional neuroimaging can provide useful biomarkers. Several treatments have been proposed, and while no clear benefits have been demonstrated, acetylcholinesterase inhibitors may be useful, especially in the logopenic variant.
Conclusions: PPA is an emerging syndrome which may be more prevalent than we might expect. It was previously listed as part of the frontotemporal dementia spectrum, and it is also related to Alzheimer disease. Clinical diagnosis, complemented by a biomarker evaluation, may predict the underlying pathology, which in turn will improve treatment possibilities.
Keywords: Afasia progresiva primaria; Alzheimer disease; Degeneración frontotemporal lobar; Demencia frontotemporal; Demencia semántica; Enfermedad de Alzheimer; Frontotemporal dementia; Frontotemporal lobar degeneration; Logopenic; Logopénica; Primary progressive aphasia; Semantic dementia; Tauopathies; Taupatías.
Copyright © 2012 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.
Similar articles
-
Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.JAMA Neurol. 2018 Mar 1;75(3):342-352. doi: 10.1001/jamaneurol.2017.4309. JAMA Neurol. 2018. PMID: 29309493 Free PMC article.
-
[Specificities of the logopenic variant of primary progressive aphasia].Rev Neurol (Paris). 2015 Jan;171(1):16-30. doi: 10.1016/j.neurol.2014.08.004. Epub 2014 Oct 13. Rev Neurol (Paris). 2015. PMID: 25444173 Review. French.
-
Classification and pathology of primary progressive aphasia.Neurology. 2013 Nov 19;81(21):1832-9. doi: 10.1212/01.wnl.0000436070.28137.7b. Epub 2013 Oct 18. Neurology. 2013. PMID: 24142474
-
Primary progressive aphasia: clinicopathological correlations.Nat Rev Neurol. 2010 Feb;6(2):88-97. doi: 10.1038/nrneurol.2009.216. Nat Rev Neurol. 2010. PMID: 20139998 Free PMC article. Review.
-
Primary progressive aphasia: diagnosis, varieties, evolution.J Int Neuropsychol Soc. 2003 Jul;9(5):710-9. doi: 10.1017/S1355617703950041. J Int Neuropsychol Soc. 2003. PMID: 12901777 Clinical Trial.
Cited by
-
Efficacy of LSVT LOUD® on Phonatory Control and Voice Quality in Patients with Primary Progressive Apraxia of Speech: Case Studies.Brain Sci. 2024 Apr 24;14(5):417. doi: 10.3390/brainsci14050417. Brain Sci. 2024. PMID: 38790396 Free PMC article.
-
Muddles and puzzles: Metaphor use associated with disease progression in Primary Progressive Aphasia.Aphasiology. 2023 Oct 16;38(6):1100-1117. doi: 10.1080/02687038.2023.2257356. eCollection 2024. Aphasiology. 2023. PMID: 38708057 Free PMC article.
-
Differences in Striatal Metabolism in [18F]FDG PET in Parkinson's Disease and Atypical Parkinsonism.Diagnostics (Basel). 2022 Dec 20;13(1):6. doi: 10.3390/diagnostics13010006. Diagnostics (Basel). 2022. PMID: 36611298 Free PMC article.
-
Dyslexia and dysgraphia of primary progressive aphasia in Chinese: A systematic review.Front Neurol. 2022 Dec 6;13:1025660. doi: 10.3389/fneur.2022.1025660. eCollection 2022. Front Neurol. 2022. PMID: 36561305 Free PMC article.
-
Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer's Disease.Biomolecules. 2021 Nov 4;11(11):1635. doi: 10.3390/biom11111635. Biomolecules. 2021. PMID: 34827633 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical